ESMO / ECC Conference Coverage
Featured Articles
(STAT Plus/Pharmalot) Oct 23, 2018 - What would you say if a cancer patient could be given a lower dose of a pricey treatment that was not only equally effective, but could also save a bundle of money? That’s the proposition being advanced by some leading oncologists, who are promoting what they call value-based prescribing, which...
Read Article
(Xconomy National) Oct 23, 2018 - The European Society for Medical Oncology is wrapping up its annual conference today, replete with clinical data from cancer’s front lines. We’ve sorted the headlines into a few big categories: immunotherapy combinations, breast cancer, lung cancer, the growing class of drugs called PARP inhibitors,...
Read Article
Latest Articles
October 23, 2018
October 23, 2018
October 23, 2018
October 23, 2018
October 23, 2018
October 23, 2018
October 23, 2018
October 23, 2018
View More
News Commentary
Editor Image
25 Oct, 2018 | by
It’s becoming overwhelming the ad on with the immunotherapy is in...
View Comment
Editor Image
22 Oct, 2018 | by H. Jack West, MD
Results of IMpower130 are certainly favorable and positive for the...
View Comment
View More
Featured Videos
There are no videos.
OBR Blog
There are no ESMO / ECC Conference Coverage blog entries.